Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
Diabetes Care
|
October 7, 1997
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
P Oskarsson, J G Ljunggren, P E Lins
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes
L Landstedt-Hallin, U Adamson, P E Lins
Diabetes & Metabolism
|
December 22, 2005
Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects
A von Dobeln, U Adamson, P E Lins
Annals of Clinical Research
|
January 1, 1978
Extrahypophyseal effects of somatostatin
S Efendić, P E Lins, K Uvnäs-Wallensten
Acta Medica Scandinavica
|
January 1, 1984
Predictability in diabetic nephropathy
J Berglund, L E Lins, P E Lins
Acta Medica Scandinavica
|
January 1, 1985
Metabolic and blood pressure monitoring in diabetic renal failure
J Berglund, L E Lins, P E Lins
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 1, 1995
Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle
E Moberg, M Kollind, P E Lins, et al.
International Journal of Microcirculation, Clinical and Experimental
|
September 1, 1994
Patients with type 1 diabetes lack vasoconstrictor response in skin microcirculation during insulin-induced hypoglycemia
G Jörneskog, P E Lins, U Adamson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
August 1, 1993
Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus
E Moberg, M Kollind, P E Lins, et al.
Acta Medica Scandinavica
|
January 1, 1982
Effect of somatostatin on insulin-induced hypoglycemia in man
U Adamson, S Efendic, P E Lins, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
Diabetes Care
|
October 7, 1997
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group
P Oskarsson, J G Ljunggren, P E Lins
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes
L Landstedt-Hallin, U Adamson, P E Lins
Diabetes & Metabolism
|
December 22, 2005
Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects
A von Dobeln, U Adamson, P E Lins
Annals of Clinical Research
|
January 1, 1978
Extrahypophyseal effects of somatostatin
S Efendić, P E Lins, K Uvnäs-Wallensten
Acta Medica Scandinavica
|
January 1, 1984
Predictability in diabetic nephropathy
J Berglund, L E Lins, P E Lins
Acta Medica Scandinavica
|
January 1, 1985
Metabolic and blood pressure monitoring in diabetic renal failure
J Berglund, L E Lins, P E Lins
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 1, 1995
Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle
E Moberg, M Kollind, P E Lins, et al.
International Journal of Microcirculation, Clinical and Experimental
|
September 1, 1994
Patients with type 1 diabetes lack vasoconstrictor response in skin microcirculation during insulin-induced hypoglycemia
G Jörneskog, P E Lins, U Adamson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
August 1, 1993
Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus
E Moberg, M Kollind, P E Lins, et al.
Acta Medica Scandinavica
|
January 1, 1982
Effect of somatostatin on insulin-induced hypoglycemia in man
U Adamson, S Efendic, P E Lins, et al.
Page
of 12